
Health Canada has approved Pfizer's new bivalent COVID-19 vaccine for usage arsenic a booster dose successful those aged 12 and up.
Health Canada has approved Pfizer's new bivalent COVID-19 vaccine for usage arsenic a booster dose successful those aged 12 and up.